DOGE-ing US FDA: Three Scenarios For What Comes Next

 
• By Michael McCaughan and Ramsey Baghdadi
  
One scenario for FDA restructuring could be combining the drug and biologics centers. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Pathways & Standards